Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.49 |
| ▸ | GHSR | Q92847 | 3/20 | 0.43 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.38 |
| ▸ | ECE1 | P42892 | 1/20 | 0.38 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.38 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.38 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.38 |
| ▸ | GNPAT | O15228 | 1/20 | 0.38 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.38 |
| ▸ | CPB2 | Q96IY4 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2247594 | 1.00 | SLC15A2 (0.49) | SLC15A2GHSRNOD1ECE1ERAP2 | |
| SCHEMBL1959809 | 0.99 | SLC15A2 (0.50) | SLC15A2GHSRNOD1ECE1ERAP2 | |
| SCHEMBL5969770 | 0.99 | SLC15A2 (0.50) | SLC15A2GHSRNOD1ECE1ERAP2 | |
| SCHEMBL1959812 | 0.99 | SLC15A2 (0.50) | SLC15A2GHSRNOD1ECE1ERAP2 | |
| Hydrochloric Acid SCHEMBL7805623 | 0.98 | SLC15A2 (0.49) | SLC15A2GHSRNOD1ECE1ERAP2 | |
| SCHEMBL4590038 | 0.98 | SLC15A2 (0.49) | SLC15A2GHSRNOD1ECE1ERAP2 | |
| SCHEMBL4589288 | 0.98 | SLC15A2 (0.49) | SLC15A2GHSRNOD1ECE1ERAP2 | |
| Acetic Acid SCHEMBL9411947 | 0.97 | SLC15A2 (0.48) | SLC15A2GHSRNOD1ECE1ERAP2 | |
| SCHEMBL8000316 | 0.96 | SLC15A2 (0.47) | SLC15A2GHSRECE1ERAP2ERAP1 | |
| SCHEMBL8000305 | 0.96 | SLC15A2 (0.47) | SLC15A2GHSRECE1ERAP2ERAP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9333159-B2 | Topical DNA repair composition | PHOTOMEDEX, INC. (US) | 2016-05-10 | — | — | US | disclosed |
| US-20140335137-A1 | Topical DNA Repair Composition | PHARMA COSMETICS LABORATORIES LTD. (IL) | 2014-11-13 | — | — | US | disclosed |
| US-20100249042-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF EYELASHES AND EYEBROWS | PROCYTE CORPORATION (US) | 2010-09-30 | — | — | US | disclosed |
| EP-1545579-A1 | COMPOSITIONS CONTAINING PEPTIDE COPPER COMPLEXES AND PHYTOCHEMICAL COMPOUNDS, AND METHODS RELATED THERETO | PROCYTE CORPORATION (US) | 2005-06-29 | — | — | EP | disclosed |
| EP-1434563-A1 | METHODS FOR THE TREATMENT OF HYPERPIGMENTATION OF SKIN | PROCYTE CORPORATION (US) | 2004-07-07 | — | — | EP | disclosed |
| WO-2004014413-A1 | COMPOSITIONS CONTAINING PEPTIDE COPPER COMPLEXES AND PHYTOCHEMICAL COMPOUNDS, AND METHODS RELATED THERETO | PROCYTE CORPORATION (US) | 2004-02-19 | — | — | WO | disclosed |
| US-20030134781-A1 | Methods for the treatment of hyperpigmentation of skin | PROCYTE CORPORATION | 2003-07-17 | — | — | US | disclosed |
| WO-2003047543-A1 | METHODS FOR THE TREATMENT OF HYPERPIGMENTATION OF SKIN | PROCYTE CORPORATION (US) | 2003-06-12 | — | — | WO | disclosed |
| EP-0765152-A1 | STIMULATION OF HAIR GROWTH BY PEPTIDE-COPPER COMPLEXES | PROCYTE CORPORATION (US) | 1997-04-02 | — | — | EP | disclosed |
| WO-1995035085-A1 | STIMULATION OF HAIR GROWTH BY PEPTIDE-COPPER COMPLEXES | PROCYTE CORPORATION (US) | 1995-12-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140335137-A1 | Topical DNA Repair Composition | ERCC1, UNG, ERCC5 | SLC15A2 2395/4885GHSR 4685/4885NOD1 3625/4885 |
| US-20100249042-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF EYELASHES AND EYEBROWS | CUTA, TYR, EYA3 | SLC15A2 2514/4885GHSR 529/4885NOD1 4770/4885 |
| US-20030134781-A1 | Methods for the treatment of hyperpigmentation of skin | RBP1, RBP4, MC1R | SLC15A2 1416/4885GHSR 345/4885NOD1 4379/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.